G

Glenmark Life Sciences Ltd
NSE:GLS

Watchlist Manager
Glenmark Life Sciences Ltd
NSE:GLS
Watchlist
Price: 1 057.2 INR 2.9% Market Closed
Market Cap: 129.5B INR
Have any thoughts about
Glenmark Life Sciences Ltd?
Write Note

Glenmark Life Sciences Ltd
Long-Term Debt

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Glenmark Life Sciences Ltd
Long-Term Debt Peer Comparison

Comparables:
CIPLA
SUNPHARMA
ZYDUSLIFE
T
TORNTPHARM
M
MANKIND

Competitive Long-Term Debt Analysis
Latest Figures & CAGR of Competitors

Company Long-Term Debt CAGR 3Y CAGR 5Y CAGR 10Y
G
Glenmark Life Sciences Ltd
NSE:GLS
Long-Term Debt
â‚ą170.9m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Cipla Ltd
NSE:CIPLA
Long-Term Debt
â‚ą2.3B
CAGR 3-Years
-43%
CAGR 5-Years
-43%
CAGR 10-Years
-3%
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
Long-Term Debt
â‚ą3B
CAGR 3-Years
-30%
CAGR 5-Years
-28%
CAGR 10-Years
20%
Zydus Lifesciences Ltd
NSE:ZYDUSLIFE
Long-Term Debt
â‚ą251m
CAGR 3-Years
-65%
CAGR 5-Years
-64%
CAGR 10-Years
-33%
T
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
Long-Term Debt
â‚ą16.7B
CAGR 3-Years
-17%
CAGR 5-Years
-16%
CAGR 10-Years
8%
M
Mankind Pharma Ltd
NSE:MANKIND
Long-Term Debt
â‚ą325.8m
CAGR 3-Years
-19%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Glenmark Life Sciences Ltd's Long-Term Debt?
Long-Term Debt
170.9m INR

Based on the financial report for Mar 31, 2024, Glenmark Life Sciences Ltd's Long-Term Debt amounts to 170.9m INR.

What is Glenmark Life Sciences Ltd's Long-Term Debt growth rate?
Long-Term Debt CAGR 1Y
0%

Over the last year, the Long-Term Debt growth was 0%.

Back to Top